To investigate the synergistic effect of EZH2 inhibitor tazemetostat and 5-FU in CRC cells, we first checked the level of EZH2, as well as other members of PRC2 complex including SUZ12 and EED in CRC cells using western blotting. Here, SUZ12 is linked to colorectal carcinoma.